CBI apprehends persons over bribery case at DCGI office, role of Joint Drugs Controller under scanner

The searches were conducted as part of this operation, officials said.

Published On 2022-06-20 12:10 GMT   |   Update On 2022-06-21 12:18 GMT

New Delhi: The Central Bureau of Investigation (CBI) on Monday apprehended some persons at the office of the Drugs Controller General of India (DCGI) in connection with a Rs three lakh alleged bribery case in which the role of Joint Drugs Controller S Eswara Reddy is under scanner, officials said.The CBI team, after getting inputs about exchange of bribery, allegedly carried out trap operation...

Login or Register to read the full article

New Delhi: The Central Bureau of Investigation (CBI) on Monday apprehended some persons at the office of the Drugs Controller General of India (DCGI) in connection with a Rs three lakh alleged bribery case in which the role of Joint Drugs Controller S Eswara Reddy is under scanner, officials said.

The CBI team, after getting inputs about exchange of bribery, allegedly carried out trap operation in which some persons were apprehended, they said.

The searches were conducted as part of this operation, they said.

Read also: HC restrains pharma companies from infringing Boehringer Ingelheim diabetes drug Linagliptin

Drugs Controller General of India (DCGI) is the head of department of the Central Drugs Standard Control Organization of the Government of India responsible for approval of licences of specified categories of drugs such as blood and blood products, IV fluids, vaccines, and sera in India. Drugs Controller General of India, comes under the Ministry of Health & Family Welfare.DCGI also sets standards for manufacturing, sales, import, and distribution of drugs in India.

Read also: Abbott Healthcare faces 5 year ban from Tamil Nadu Govt agency: Report







Tags:    
Article Source : with inputs

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News